08.26.25 -- STREAM Edition: Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter Three

Discover how perfusion-based medium exchange and optimized oxygenation strategies overcome scale-up challenges in PSC cultures to ensure consistent growth, uniformity, and high-quality results.

Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.

Experts on this Cell & Gene live event discuss the major scientific biological advances in understanding the potential for mRNA-based immunotherapies vaccines for cancer over the last 2 years.

By exploring the integration of advanced manufacturing platforms, you can discover how to improve biological performance and leverage the economic and operational benefits of closed systems.

Watch part 3 of a four-part series, "Four Common Types Of Cryogenic Studies For Advanced Therapies," to learn about therapy containment/protection studies.

Learn the principles of commercialization readiness and guidance to address them in process development as well as the best time to implement automation and minimize commercialization risks.

Explore a platform that adapts to your evolving workflow through real-world examples of how its flexibility supports diverse inputs, applications, and parameters to ensure consistency and scalability.

 On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy.

Discover how decades of clinical expertise and cutting-edge automation can streamline your manufacturing workflows, boost consistency, and drive scalable, compliant bioprocessing.